GRADE 2 FOLLICULAR LYMPHOMA
Clinical trials for GRADE 2 FOLLICULAR LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new GRADE 2 FOLLICULAR LYMPHOMA trials appear
Sign up with your email to follow new studies for GRADE 2 FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Low-Dose drug shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests whether a low dose of the drug mosunetuzumab is safe and works well for people with slow-growing B-cell lymphoma who have not had treatment before. About 20 adults with stage II to IV follicular or marginal zone lymphoma will receive the drug to see if it shrinks…
Matched conditions: GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 17, 2026 07:51 UTC
-
New drug combo shows promise for untreated lymphoma patients
Disease control Recruiting nowThis study tests a combination of two drugs, acalabrutinib and obinutuzumab, in people with untreated, slow-growing types of non-Hodgkin lymphoma, including follicular lymphoma. The goal is to see if this drug pair can shrink or eliminate cancer. About 49 adults will take part. T…
Matched conditions: GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy shows promise for Hard-to-Treat lymphoma
Disease control Recruiting nowThis study tests whether combining two drugs, pirtobrutinib and mosunetuzumab, can better treat follicular lymphoma that has returned or not responded to prior therapies. About 22 adults with grade 1-3a lymphoma will receive the combination. The goal is to improve cancer remissio…
Matched conditions: GRADE 2 FOLLICULAR LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated May 11, 2026 20:41 UTC